Modulation of GUT dysbiosis with enterobacteriaceae-targeted antiproliferative agents to treat inflammatory bowel disease
Ended Project Grant Awarded Last action
- Award ID
- R43DK121564
- Recipient
-
Symberix, Inc. UEI HN72U2V5AKN7
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $231,302
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Place of performance
- Durham, NC 27703, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $231,302 |
Quick answers
Who received award R43DK121564?
R43DK121564 was awarded to Symberix, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on May 1, 2019.
How much is award R43DK121564 worth?
$231,302 has been obligated on R43DK121564.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award